Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia.
Open Access
- 1 March 1986
- journal article
- research article
- Published by BMJ in British Journal of Ophthalmology
- Vol. 70 (3) , 166-173
- https://doi.org/10.1136/bjo.70.3.166
Abstract
Six patients with abetalipoproteinaemia are described who received large doses of oral vitamin E for between 12 and 18 years in addition to a low fat diet and supplements of the other fat soluble vitamins. The progressive retinopathy observed in untreated abetalipoproteinaemia was substantially modified and most probably prevented by this therapy. Angioid streaks were noted in one patient. Treatment with vitamin A alone did not prevent or arrest the progression of the retinal lesion.This publication has 28 references indexed in Scilit:
- Angioid streaks in a case of beta thalassaemia major.British Journal of Ophthalmology, 1983
- Nervous and Ocular Disorders in Children with Cholestasis and Vitamin A and E DeficienciesHepatology, 1983
- Combined vitamin A and E therapy prevents retinal electrophysiological deterioration in abetalipoproteinaemia.British Journal of Ophthalmology, 1982
- EFFECT OF LARGE ORAL DOSES OF VITAMIN E ON THE NEUROLOGICAL SEQUELAE OF PATIENTS WITH ABETALIPOPROTEINEMIAAnnals of the New York Academy of Sciences, 1982
- Long-term management of abetalipoproteinaemia. Possible role for vitamin E.Archives of Disease in Childhood, 1977
- The relative importance of the factors involved in the absorption of vitamin E in childrenGut, 1974
- Vertebrate rod outer segment membranesBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1973
- A-β-lipoproteinämie bei drei GeschwisternDeutsche Medizinische Wochenschrift (1946), 1972
- Alpha-tocopherol in the retinal outer segment of bovine eyesThe Journal of Membrane Biology, 1970
- A- -lipoproteinaemiaArchives of Disease in Childhood, 1965